- Enrollment
- 50
- Started
- May 2024
- Completion
- Dec 2026
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2026
Therapeutic-area index
Brain healthPeptide Trials.
Explore peptide clinical trials tagged to the brain health condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.
- Studies
- 70
- Recruiting
- 17
- Completed
- 31
- Results posted
- 9
- Countries
- 26
- Avg enrollment
- 162
Velocity
Brain health trials by start year
Study start year · indexed snapshot
Development
Trials by phase
42phase labels
Early Phase 11
Phase 15
Phase 224
Phase 36
Phase 46
Industry
Leading sponsors
Allon Therapeutics2
Axial Therapeutic Research1
Motus Therapeutics, Inc.1
Neuraly, Inc.1
Regeneron1
Therapeutic areas
Condition groups
Brain health70
Longevity7
Weight loss7
Inflammation4
Pain4
Type 2 diabetes2
Compound leaders
Most represented peptides.
Study explorer
Search this collection.
70 matching studies
Last registry update first
- Enrollment
- 80
- Started
- Jan 2024
- Completion
- Dec 2028
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2026
- Enrollment
- 40
- Started
- Sep 2025
- Completion
- Jun 2027
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2026
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
LiraglutideGlucagonThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolType 2 Diabetes Mellitus · Mild Cognitive Impairment
- Enrollment
- 396
- Started
- Oct 2022
- Completion
- Jul 2026
- Locations
- 5
- Countries
- 1
- Updated
- Jul 2026
- Enrollment
- 52
- Started
- Aug 2022
- Completion
- Nov 2026
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2026
- Enrollment
- 40
- Started
- Aug 2025
- Completion
- Aug 2029
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2026
- Enrollment
- 213,891
- Started
- Jan 2007
- Completion
- Jun 2026
- Locations
- 1
- Countries
- 1
- Updated
- Jul 2026
- Enrollment
- 200
- Started
- Jan 2023
- Completion
- Dec 2030
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2026
- Enrollment
- 180
- Started
- Nov 2020
- Completion
- Jul 2026
- Locations
- 3
- Countries
- 1
- Updated
- Jun 2026
- Enrollment
- 90
- Started
- Apr 2025
- Completion
- Apr 2026
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2026
- Enrollment
- 121
- Started
- Jun 2023
- Completion
- Sep 2024
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2026
- Enrollment
- 200
- Started
- Sep 2019
- Completion
- Sep 2029
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2026
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
NesiritideChina National Center for Cardiovascular DiseasesAKI - Acute Kidney Injury · Cardiac Surgical Procedures
- Enrollment
- 694
- Started
- May 2026
- Completion
- Jul 2029
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2026
- Enrollment
- 57
- Started
- Feb 2020
- Completion
- Nov 2026
- Locations
- 3
- Countries
- 1
- Updated
- May 2026
Spironolactone Therapy in Chronic Stable Right HF Trial
NesiritideOttawa Heart Institute Research CorporationChronic Right-Sided Heart Failure · Pulmonary Arterial Hypertension
- Enrollment
- 15
- Started
- Apr 2018
- Completion
- May 2024
- Locations
- 1
- Countries
- 1
- Updated
- May 2026
- Enrollment
- 194
- Started
- Jan 2020
- Completion
- Jul 2024
- Locations
- 1
- Countries
- 1
- Updated
- May 2026
- Enrollment
- 32
- Started
- Jun 2026
- Completion
- Jun 2027
- Locations
- 1
- Countries
- 1
- Updated
- May 2026
- Enrollment
- 240
- Started
- Oct 2024
- Completion
- Sep 2028
- Locations
- 1
- Countries
- 1
- Updated
- May 2026
- Enrollment
- 28
- Started
- Nov 2016
- Completion
- Jun 2027
- Locations
- 1
- Countries
- 1
- Updated
- May 2026
- Enrollment
- 93
- Started
- Apr 2026
- Completion
- Jan 2027
- Locations
- 0
- Countries
- 0
- Updated
- Apr 2026
- Enrollment
- 73
- Started
- Feb 2017
- Completion
- Oct 2023
- Locations
- 4
- Countries
- 1
- Updated
- Mar 2026
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
MazdutideThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolDementia, Mild · Mild Cognitive Impairment
- Enrollment
- 420
- Started
- Sep 2025
- Completion
- Aug 2029
- Locations
- 8
- Countries
- 1
- Updated
- Mar 2026
- Enrollment
- 80
- Started
- Feb 2025
- Completion
- Jun 2026
- Locations
- 2
- Countries
- 1
- Updated
- Feb 2026
- Enrollment
- 786
- Started
- Mar 2026
- Completion
- Dec 2029
- Locations
- 6
- Countries
- 1
- Updated
- Jan 2026